Letter to the editor—comments on Kleckner et al. (2018) “Effects of exercise during chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial”
We read with interest the recent article by Kleckner et al.  examining the effects of a 6-week exercise program (EXCAP©®) among 355 cancer survivors (breast, lymphoma, colon, lung, and other) on chemotherapy-induced peripheral neuropathy (CIPN). We agree that CIPN is an important patient outcome in the exercise and cancer field. In their trial, the authors concluded “exercise appears to reduce CIPN symptoms in patients receiving taxane-, platinum-, or vinca alkaloid-based chemotherapy.” (p. 1019). In our opinion, while the study shows potentially positive trends, the conclusions drawn by the authors may be somewhat premature.
The authors stated, “Exercise reduced CIPN symptoms of hot/coldness in hands/feet (-0.46 units, p=0.045) and numbness and tingling (-0.42 units, p=0.061) compared to the control. Exercise reduced CIPN symptoms more for patients who were older (p=0.086), male (p=0.028), or had breast cancer (p=0.076).” (p. 1019). Table 2 and Figure 2 in the Kleckner et al....
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Kleckner I, Kamen C, Gewandter JS, Mohile NA, Heckler CE, Culakova E, Fund C, Janelsins MC, Asare M, Po-Ju L, Reddy PS, Giguere J, Berenberg J, Kesler SR, Mustian KM (2018) Effects of exercise during chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer 26:1019–1028CrossRefGoogle Scholar
- 3.Mendoza TR, Zhao F, Cleeland CS, Wagner LI, Patrick-Miller LJ, Fisch MJ (2013) The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the Symptom Outcomes and Practice Patterns Data from the Eastern Cooperative Oncology Group. Clin Breast Cancer 13(5):325–334CrossRefPubMedPubMedCentralGoogle Scholar